Articles
| Open Access |
DOI: The Prevalence Of Metabolic Syndrome In Older People: “Attitude Towards Population Success”
Mamasoliev N.S. , Andijan State Medical Institute, Uzbekistan Tursunov Kh.Kh. , Bukhara State Medical Institute, Uzbekistan Rajabova G.Kh. , Bukhara State Medical Institute, UzbekistanAbstract
The problem of various components of MS is at the center of attention of modern medical science and healthcare.
Kazno Toushita reports (2018) that in Japan, almost half of Japanese men and a quarter of Japanese women are either visceral obesity or overweight, and that the number of such patients increases with age. There fore, a special prevention program was launched in 2008, and now medical insurance companies must provide annual check-ups for all people between the ages of 40 and 75.
Keywords
Blood pressure, metabolic syndrome, older people
References
Aronov D.M. Physical training programs for the prevention of cardiovascular complications in apparently healthy people with various risk factors for coronary artery disease. Methodical recommendations // Preventive medicine.-2014.-17(3):63-65.
Belenkov Yu.N., Chazova I.E., Mychki V.B. Multicenter randomized open-label study to study the effectiveness of lifestyle changes and therapy with ACE inhibitors (quinapril) in patients with obesity and arterial hypertension (IVF) // Art. hypert. 2003; 9(6): 196-8.
Boytsov S.A., Chuchalina A.G. Prevention of chronic non-communicable diseases. A practical guide. M.: GNITsPM.-2013.
Bokarev I.N., Dunin P.A., Ovchinnikov Yu.V. Arterial hypertension: current state of the problem // Clinical medicine.-2017-Vol. 95.-№7-P.581-585.
Bganyan R.A., Kalinina A.M., Karamnova N.S., Ipatov P.V. et al. Methodological aspects of identifying and correcting alimentary-dependent risk factors for cardiovascular diseases in the course of clinical examination of certain groups of the adult population of Russia // Preventive Medicine.-2015.-№1.-P.3.
Verbovoy A.F., Pashentseva A.V., Sharapova L.L. Obesity and the cardiovascular system // Clinical medicine -2017.-95 (1).-№1.-P.31-34.
Gruzdeva O.V., Palicheva E.I., Maksimov S.A. et al. Metabolic risk factors for the development of diseases of the circulatory system in different age groups // Clinical recommendation:-2017.- Vol 95.-№11.-P.1035-1040.
Kobyakova O.S., Kulikov E.S., Deev I.A., Almikeeva A.A., et al. The frequency of risk factors for chronic non-infectious diseases among doctors in the Russian Federation on the model of the Tomsk region // Cardiovascular therapy and prevention.-2018:17(6).-P.-44-50.
Karpov Yu.A., Shubina A.T. Reducing the risk of complications in metabolic syndrome: the role of a fixed combination of losartan and amlodipine // Atmosphere. Cardiology news. -2016.-№3.-P. 29-34.
Cardiology. National leadership. 2nd edition, revised and enlarged // Edited by Academician E.V. Shlyakhto.-Moscow.-2019-P.391.
Casio Tushita. Measures to prevent visceral obesity and cardiovascular risk factors: the essence and results of a lifestyle change program aimed at combating metabolic syndrome in Japan // VII International Internet Congress of Specialists in Internal Medicine. - Moscow.-VIDOX -2018.-P.9-10.
Korneeva O.N., Drapkina O.M., Ivashkin V.T. Clinical variants of metabolic syndrome -2007.
Mamedov M.N. Metabolic syndrome in Russia: prevalence, clinical features and treatment. Moscow: News of the Administrative Department of the President of the Russian Federation. -2011.
Mohort T.V., Mohort E.G. Cognitive impairments and diabetes mellitus: prevention and treatment options // Health of Uzbekistan. -2016-№(04)-P.66-67.
Ochanov R.G., Kalinina A.M., Pozdnyakov Yu.M. Preventive cardiology. -Moscow -2003.-P.33-36.
The first results of the Russian program "April" (The effectiveness of the use of acarbose in patients with impaired glucose tolerance and arterial hypertension // Obese metabolic 2005; 1(3): 13-1.
Popov V.V., Novikova I.A., Prokhova M.V., Litvyakova M.L. and others. Early diagnosis and prevention of age-associated disorders in elderly and senile people living in the European North of Russia // Preventive Medicine.-2019-№3-P.77.
Prevention of chronic non-communicable diseases. Russian recommendations // Ed. Boitsova S.A.-Moscow -2013-P.75-76.
Strazheeko I.D., Akasheva D.U., Dudinskaya E.N., Tkacheva O.N. Aging of blood vessels: main signs and mechanisms // Cardiovascular therapy and prevention -2012; 11(4): 95-99.
Shubina A.L., Demidova I.Yu., Karpov Yu.A. metabolic syndrome X: prerequisites for the development of arterial hypertension and atherosclerosis // Clinical Pharmacology and Therapy.-2001;10(4):45-46.
Shapiro I.A. Secondary prevention of cardiovascular diseases at the level of outpatient clinics in the context of health care reforms // Author. doct. diss.-M.-2002.
Degtyarev V.A. On the question of determining blood pressure by auscultatory method // Functional diagnostics -2007;(2): 6-10.
Diagnosis and treatment of metabolic syndrome. Russian recommendations. –Moscow // Appendix 2 to the journal "Cardiovascular Therapy and Prevention" 6/6.-P.4-5.
Drapkina O.M. Metabolic syndrome: cardiovascular and gastroenterological comorbidity // III International Internet Congress of Specialists in Internal Medicine - Moscow.VIDOX-2018.
Chazova I.E., Mychka V.B. Metabolic syndrome. М:Media Medica.2004-P.48-49.
Chazova I.E., Mychka V.B. Multicenter, randomized, scientific and practical program MINOTAVR: intermediate analysis of the results // Kardiovask. ter. profile 2006; 2:81-6.
Alwan A. The World Report of Non communicable Diseases // WHO library Cataloguingin Publication Data: General, 2013- P. 161.
Bykov A.T. , Malyarenko T.N. , Dynrhykov A.A. et al. About efficacy of the training exercises in rehabilitation of the patients undergoing surgical myocardial revascularization // Medical Bulleten of the South of Russia.-2012; 3:7-15.
Borch – Sohnsen K., Wareham N. The risk and fall of the metabolic syndrome // Diabetalogia. -2010;53(4):597-598
https://www.who.int/Features/Fartfiles/ageing/ru/index.html.
Franklin S.S. Do Diabetes and hypertension interact to accelerate vascular ageing? // J Jlypertens 2002 ; 20(9) : 1699-1664.
Gandhi H.K., Vaishali V., frem R. et al A survecy on physical activity and noncommunicable diseacal risk factors among physicians in terriary care hos pitals, Mangalor. //Nat J Commun Med.2012; 3(1):7-12.
Hanefeld M., Pistrosh F., Schulze J.et al. The metabolic syndrome and cardiovascular diseases: an update of medical theatment //J Metabolic Synd 2014; 3(4): 160-165.
2003 European Society of Hypertension – European Society Cardiology Guidelines for the management of arterial hypertension // J Hypertens-2003; 21:1011-52.
Kynene Sh, Taukobong NP. Dietary habits among health professionals working in a district hospital in Kwazulu-Natal, South Africa // Afr J prim Health Care Fam Med. 2017;9(1): 1364.doi:10.4102/phefm. V9:1.1364.
Mazzali M., Kanellis J., Han L. et al. Hyperuricemia induces a primary renal arteberiolopathy in rats 64-nism // Am J Physial Renal Physial .2002;282:f 991-
Milions H., KaKafika A. Effects of Statin Treatment on Uric Acid Homeostasis in Patients with Primary Hyperlipidemia //Am Hearth J 2004; 148 (4):636-39.
Nillson P.M. Hemodynamic aging as the coseguence of structural changes associated with Early Vascular Aging (EVA) //Aying Dis 2014; 5(2):110-112.
Nilsson P.M., Lurbe E., Lanrent S. Thelarly life oriyns of vascular ageing and cardiovascular ageing risk: the EVA syndrome //Hypertens 2008; 26(6):1049-1055.
Makladalona M., Sovova E., Ivanova K. et al Risk Factors For cardiovascular diseases in physicians //J.Blomed.Pap.Med.Fac.Univ.
Oganov R.G., Maslennikova C.V., Tyurina T.V. et al. How to help smoking patients : new opportunities // Кардиоваскулярная терапияю -2011-10(5). –С.4-6.
Paulweber B., Valensi P., Kindsfrom J. European Evidense-Based Guideline for the Prevention of Type 2 Diabetes // Horm and Metab Research 2010 ; 42(suppl.1) : 3-31.
Seobodyyanyuk A.L., Krylova J.A., Kyraev V.I. Primary care : now to increase physical activity in your patients // Archives of Internal Medicine -2019;9(4) : 269-279. Doi : 10-20514 / 2226-6704-2019.9-4-269-279.
Standatr FC, Durkin MN,Blair SN. Determining levels of physical activity in attending physicians , resident and fellow Physicians and fellow physicians and medi physicians resident and fellow physicians and medical students in the USA // Br J Sports Med . -20102; 46(5) : 360.4. doi : 10.1136//bisports -2011-090299.
Verdecchial P., Schillaci G., Reboldi G. et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension // The PIUMA study. Hypertension 200; 36 : 1073-8.
Ryden L., Grant P.I., Ankon S.D., BerneC., Cosentino F., Danchin N. et al. ESC Guidelineson diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD : The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European society of Cardiology (ESC) and developed in collaboration with the European Association for the dtudy of Diabetes [EASD] // Eur Heart J 2013; 34 (39) : 3035-3085.
World Health Statistics 2014. World Health Organization.
Zimmed P., Shaw J., Alberti G. Preventing type 2 diabetes and the dysmetobolic syndrome in the world : a realistic view. Diabetic medicine 2003; 20(9) : 693-701.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.